Breaking Finance News

Heska Corp (NASDAQ:HSKA) has been downgraded to Hold in a report by Zacks Investment Research today.

Zacks Investment Research has downgraded Heska Corp (NASDAQ:HSKA) to Hold in a report released on Wednesday October 05, 2016.

On Monday September 26, 2016, B. Riley released a statement for Heska Corp (NASDAQ:HSKA) raised the target price from $0.00 to $53.00 that suggested a downside of -0.03%.

Yesterday Heska Corp (NASDAQ:HSKA) traded -0.02% lower at $53.92. Heska Corp’s 50-day average is $53.88 and its two hundred day average is $41.29. With the last close up 32.85% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same period. 109,233 shares of Heska Corp exchanged hands, up from an avg. volume of 98,768

See Chart Below

Heska Corp (NASDAQ:HSKA)

Heska Corp has a PE ratio of 55.57 with a one year low of $26.26 and a one year high of $57.41 HSKA’s total market value is presently $0.

Also covering Heska Corp's target, a total of 4 equity analysts have released a ratings update on Heska Corp. The 12-month price target is $39.88 with 1 broker rating the stock a strong buy, 3 firms rating the stock a buy, 0 analysts rating the company a hold, zero equity analysts rating the company a underperform, and lastly 0 brokerages rating the stock a sell.

General Company Details For Heska Corp (NASDAQ:HSKA)

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.